This medical device is intended to enable continuous subcutaneus insulin infusion (CSII) by replaying the function of the pancreas. It is possible to connect a glucose sensor to the device allowing continuous blood glucose monitoring (CGM). This device is used by patients with type 1 or type 2 diabetes as an alternative insulin treatment to multi-injection insulin administration. Not considering the glucose sensor, the insulin pump (Omnipod) consists in a pod with a needle that delivers insulin and a pdm (personal diabetes manager) which delivers insulin in a programmed wireless way. Insulin is administered both continuously (basal insulin) and at mealtimes, when blood glucose rises quickly (bolus insulin).